Cite
HARVARD Citation
Serper, M. et al. (2018). Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct‐acting antiviral therapy for chronic hepatitis C: Data from a national US cohort. Journal of viral hepatitis. 25 (2), pp. 187-197. [Online].